SCHEMBL3261670

SCHEMBL3261670

COc1ccccc1C(c1ccccc1)c1ccccc1OC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.58
TDO2 P48775 1/20 0.58
CA1 P00915 3/20 0.52
CA2 P00918 3/20 0.52
CA7 P43166 2/20 0.52
CA9 Q16790 2/20 0.52
CA12 O43570 1/20 0.52
CA4 P22748 1/20 0.52
CA14 Q9ULX7 1/20 0.52
CYP19A1 P11511 1/20 0.47
L3MBTL1 Q9Y468 2/20 0.46
ATM Q13315 1/20 0.46
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
POLB P06746 1/20 0.44
HTT P42858 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
MAPT P10636 2/20 0.44
CRHBP P24387 1/20 0.44
CRHR2 Q13324 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3039320 0.95 IDO1 (0.58) IDO1TDO2CA1CA2CA7
Dimethylamine SCHEMBL10775263 0.94 IDO1 (0.53) IDO1TDO2CA1CA2CA7
SCHEMBL4660269 0.89 CA1 (0.53) IDO1TDO2CA1CA2CA7
Diethylamine SCHEMBL10775223 0.87 MEN1 (0.47) IDO1TDO2CA1CA2CA7
SCHEMBL2066662 0.85 CA1 (0.63) IDO1TDO2CA1CA2CA7
SCHEMBL10781906 0.84 MEN1 (0.53) IDO1TDO2L3MBTL1ATMMEN1
SCHEMBL31145921 0.82 MEN1 (0.50) IDO1TDO2CA1CA2CA7
SCHEMBL9253586 0.82 CASR (0.47) IDO1TDO2CA4L3MBTL1MEN1
SCHEMBL5921935 0.81 L3MBTL1 (0.50) IDO1TDO2L3MBTL1ATMPOLB
SCHEMBL28155117 0.81 IDO1 (0.53) IDO1TDO2CA1CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5419966-A Solid support for synthesis of 3'-tailed oligonucleotides MICROPROBE CORPORATION (US) 1995-05-30 US claimed
CN-118755463-A Low interfacial tension nano fluid oil displacement agent and preparation and application thereof 成都欧美克石油科技股份有限公司 2024-10-11 CN disclosed
CN-114845992-A Amorphous solid succinylated 3- (fatty acid amido) -2-hydroxy-1- (protected hydroxy) -propane salts and process for their preparation 美国杰龙生物医药公司 2022-08-02 CN disclosed
US-8461385-B2 Manufacture process of organic compounds NOVARTIS AG (CH) 2013-06-11 US disclosed
US-8362234-B2 Solid support reagents for synthesis ARCHEMIX LLC 2013-01-29 US disclosed
US-20100041866-A1 Solid Support Reagents for Synthesis ARCHEMIX CORP. (US) 2010-02-18 US disclosed
US-20090253811-A1 MANUFACTURE PROCESS OF ORGANIC COMPOUNDS NOVARTIS AG (CH) 2009-10-08 US disclosed
EP-2012810-A2 SOLID SUPPORT REAGENTS FOR SYNTHESIS Archemix Corp. (US) 2009-01-14 EP disclosed
WO-2007126941-A2 SOLID SUPPORT REAGENTS FOR SYNTHESIS ARCHEMIX CORP. (US) 2007-11-08 WO disclosed
EP-0703498-B1 Photosensitive resin composition and method for forming a photoresist pattern MITSUBISHI CHEM CORP (JP) 1997-12-29 EP disclosed
US-5698362-A CONTAINING A TRIARYLMETHANE DERIVATIVE; HIGH RESOLUTION, EXCELLENT IN DEPTH OF FOCUS AND PATTERN PROFILE, STORAGE STABLE MITSUBISHI CHEMICAL CORPORATION (JP) 1997-12-16 US disclosed
EP-0703498-A1 Photosensitive resin composition and method for forming a photoresist pattern MITSUBISHI CHEMICAL CORPORATION (JP) 1996-03-27 EP disclosed
US-5419966-A Solid support for synthesis of 3'-tailed oligonucleotides MICROPROBE CORPORATION (US) 1995-05-30 US disclosed
EP-0156912-A1 TEMPERATURE SUPERVISION AND DISPLAY UNIT MITSUI TOATSU CHEMICALS, Inc. (JP) 1985-10-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253811-A1 MANUFACTURE PROCESS OF ORGANIC COMPOUNDS NT5C, AADAC, DDC IDO1 778/4885TDO2 305/4885CA1 192/4885
US-20100041866-A1 Solid Support Reagents for Synthesis C1R, CBR1, CBR3 IDO1 3229/4885TDO2 2679/4885CA1 2203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.